Distinct chromatin patterns linked to heart development

Distinct chromatin patterns linked to heart development
Distinct chromatin patterns accompany the development of heart cells from embryonic cells, providing a blueprint that could help identify the causes of congenital heart disease, according to a study published online Sept. 13 in Cell.

(HealthDay)—Distinct chromatin patterns accompany the development of heart cells from embryonic cells, providing a blueprint that could help identify the causes of congenital heart disease, according to a study published online Sept. 13 in Cell.

Joseph A. Wamstad, Ph.D., from the Massachusetts Institute of Technology in Cambridge, and colleagues analyzed the epigenetic changes that occur during the directed differentiation of mouse into cardiomyocytes and used chromatin marks to identify patterns associated with stage-specific development.

The researchers found that distinct chromatin patterns were associated with stage-specific gene expression and could predict sets of functionally related genes, some of which were associated with human disease. In addition, a novel preactivation chromatin pattern was found at the promoters of specific cardiac genes involved in cardiac development and function. They also identified stage-specific distal enhancers that predicted novel transcriptional regulatory networks during differentiation as well as potential new regulators of cardiac development.

"Together, these findings form a basis for understanding developmentally regulated chromatin transitions during lineage commitment and the molecular etiology of ," Wamstad and colleagues conclude.

One author is a scientific founder of iPieirian and is on the scientific advisory boards of iPieirian and RegeneRx Pharmaceuticals.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Tracking genes' remote controls

Jan 09, 2012

As an embryo develops, different genes are turned on in different cells, to form muscles, neurons and other bodily parts. Inside each cell's nucleus, genetic sequences known as enhancers act like remote controls, ...

Recommended for you

Researcher studies protein's link to heart disease

Jun 18, 2013

(Medical Xpress)—The largest protein known to exist in the human body functions as a molecular spring, and University of Arizona researchers are gaining new insights into its role in heart disease.

The rhythm of everything

Jun 18, 2013

Dawn triggers basic biological changes in the waking human body. As the sun rises, so does heart rate, blood pressure and body temperature. The liver, the kidneys and many natural processes also begin shifting ...

User comments

More news stories

Laughing gas does not increase heart attacks

(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk ...

Model recreates wear and tear of osteoarthritis

(Medical Xpress)—There's a reason osteoarthritis is often called wear-and-tear arthritis: Repeated stress on joints over time results in degeneration of the soft cartilage that normally distributes loads ...

Taxing unhealthy food spurs people to buy less

Labeling foods and beverages as less-healthy and taxing them motivates people to make healthier choices, finds a recent study in the American Journal of Preventive Medicine. When faced with a 30 percent tax on ...

Renewed hope in a once-abandoned cancer drug class

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

New technologies for retinal therapies

The future of the investigation and treatment of retinal disorders is already here at the MedUni Vienna: in the new Christian Doppler "OPTIMA" (Ophthalmic Image Analysis) laboratory headed by Ursula Schmidt-Erfurth, ...

Protalix signs supply deal with Brazilian govt

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...